Webinars

ASA-BI Statistics Webinar Series # 1

  • Topic: Bayesian designs in oncology clinical trials
  • Speaker: Dr. Lili Zhao, Research Assistant Professor, Biostatistics Department, University of Michigan, USA
  • Abstract
  • Date: July 25th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 2

  • Topic: How the ICH E9 addendum around estimands may impact our clinical trials
  • Speaker: Dr. Frank Bretz, Global Head, Statistical Methodology and Consulting Group, Novartis, Switzerland
  • Abstract
  • Date: August 17th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 3

  • Topic: Impact of model complexity on operating characteristics of adaptive dose-finding methods
  • Speakers: Dr. Alexia Iasonos, Associate Attending Biostatistician, Memorial Sloan Kettering Cancer Center and Dr. Nolan Wages, Associate Professor, University of Virginia, USA
  • Abstract
  • Date: September 11th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 4

  • Topic: Phase I trials design with dose expansion cohort
  • Speaker: Dr. Jincheng Shen, Assistant Professor, Department of Population Health Sciences, University of Utah, USA
  • Abstract
  • Date: October 17th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides: Upon request

ASA-BI Statistics Webinar Series # 5

  • Topic: Blinded ongoing aggregate safety evaluation (Blinded-OASE)
  • Speaker: Dr. Greg Ball, Principal Statistician and Dr. William (Bill) Wang, Executive Director, Merck Pharmaceuticals, Inc.
  • Abstract
  • Date: November 8th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 6

  • Topic: Assessing covariate effects using Jeffrey’s-type prior in the Cox model in the presence of a monotone partial likelihood
  • Speaker: Dr. Jing Wu, Assistant Professor, University of Rhode Island, USA
  • Abstract
  • Date: December 6th, 2017
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 7

  • Topic: Dose-escalation trials without monotonicity assumption: A weighted differential entropy approach
  • Speaker: Dr. Thomas Jaki, Professor of Statistics, Lancaster University, UK
  • Abstract
  • Date: February 27th, 2018
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A
  • Slides

ASA-BI Statistics Webinar Series # 8

  • Topic: EMPA-REG Outcome® - A Cardiovascular Outcome Trial designed according to the FDA Guidance “Diabetes Mellitus– Evaluating Cardiovascular Risk in New Anti-diabetic Therapies to Treat Type 2 Diabetes”
  • Speaker: Dr. Stefan Hantel, Therapeutic Area Statistician, Boehringer Ingelheim, Germany
  • Abstract
  • Date: April 5th, 2018
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A

ASA-BI Statistics Webinar Series # 9

  • Topic: A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic data
  • Speaker: Dr. Amy Cotterill, Senior Statistician, Cancer Research UK Clinical Trials Unit, University of Birmingham, UK
  • Abstract
  • Date: April 24th, 2018
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A

ASA-BI Statistics Webinar Series # 11

  • Topic: The Future is Now, but Where We Should Focus
  • Speaker: Dr. Haoda Fu, Research Advisor at Eli Lilly and Company and Adjunct Professor in Biostatistics at Indiana University School of Medicine
  • Abstract
  • Date: July 12th, 2018
  • Time: 9:00-10:00 EST (New York), including 10-minute Q&A